InvestorsHub Logo
Followers 0
Posts 19
Boards Moderated 0
Alias Born 11/12/2017

Re: None

Friday, 01/12/2018 11:14:36 PM

Friday, January 12, 2018 11:14:36 PM

Post# of 16911
The part that I find extremely puzzling is that Apple Tree Partners, who owns Braeburn Pharmaceuticals, also owns numerous treatment centers. One would think that promoting the use of Probuphine at company owned treatment centers would be relatively straightforward for Apple Tree. On the other hand, who needs treatment centers if a "cure" is readily available? Its possible that they came to the conclusion that demand for treatment centers would quickly evaporate if they started treating everyone with Probuphine.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News